Pharmaceuticals

Therapeutic BCG Vaccines Market Expansion Outlook: $75.46 Billion by 2029 Forecast

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Predicted Market Size Trajectory For The Therapeutic BCG Vaccines Market From 2025 To 2034?

The therapeutic bcg vaccines market size has consistently expanded in recent years. It is projected to grow from $56.47 billion in 2024 to $59.09 billion in 2025, at a compound annual growth rate (CAGR) of 4.6%. The expansion witnessed during the historic period can be attributed to government initiatives for tb control, immune system modulation, global immunization programs, the treatment of bladder cancer, investments in vaccine manufacturing, and the emergence of drug-resistant tb strains.

The therapeutic bcg vaccines market size is projected to undergo substantial expansion in the upcoming years, with an anticipated increase to $75.46 billion by 2029, achieving a compound annual growth rate (CAGR) of 6.3%. This growth during the forecast period is primarily driven by the extension to additional indications, intensified research into immunotherapy, global endeavors against novel infectious diseases, regulatory assistance for vaccine innovation, and a concentrated effort on eradicating tuberculosis. Notable trends anticipated in this period encompass progress in vaccine technology, enhanced supply chain efficiency, market consolidation and strategic alliances, increased patient understanding and public information, diverse delivery methods, and customized medical approaches.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9178&type=smp

What Are The Main Drivers Boosting The Therapeutic BCG Vaccines Industry’s Expansion?

A growing global incidence of tuberculosis (TB) is set to stimulate the expansion of the therapeutic BCG vaccine market in the future. Tuberculosis (TB) is a contagious and potentially severe disease primarily affecting the lungs. It spreads from person to person through airborne droplets expelled by coughing or sneezing. BCG vaccines work by boosting the immune system to combat infections without causing TB itself, as they contain weakened germs. This vaccine consistently offers defense against the most severe forms of TB, including adolescent TB meningitis. The protection provided by the BCG vaccine against tuberculosis, which helps in fighting infections, has led to a rise in the adoption of therapeutic BCG vaccines. As an illustration, a report released in February 2024 by the UK Health Security Agency, a government body based in the UK, revealed a 10.7% surge in tuberculosis (TB) cases in England during 2023, with 4,850 cases recorded against 4,380 in 2022. Consequently, the increasing global prevalence of tuberculosis (TB) is fueling the growth of the therapeutic BCG vaccine market.

What Are The Major Segments Identified In The Therapeutic BCG Vaccines Market?

The therapeutic bcg vaccines market covered in this report is segmented –

1) By Type: Therapy BCG, Immune BCG

2) By Demographics: Pediatrics, Adults

3) By End Use: Hospitals, Clinics, Other End Users

Subsegments:

1) By Therapy BCG: Intravesical BCG, Injectable BCG

2) By Immune BCG: BCG For Immune Enhancement, BCG For Allergy Treatment

What Long-Term Trends Will Shape The Future Growth Of The Therapeutic BCG Vaccines Industry?

Strategic alliances have emerged as a significant and increasingly popular trend within the therapeutic BCG vaccine market. Major companies operating in this market are concentrating on collaborating with other key players to sustain their competitive position. For example, in May 2024, ImmunityBio, a US-based biotechnology company, formed a partnership with Serum Institute of India, an India-based biotechnology and biopharmaceuticals company, to ensure the supply of the Bacillus Calmette-Guerin (BCG) vaccine for all cancer types. This collaboration focuses on manufacturing the standard BCG (sBCG), approved for use outside the US, and a next-generation recombinant BCG (iBCG) which is currently undergoing trials. The iBCG is intended for concurrent use with ImmunityBio’s ANKTIVA (nogapendekin alfa inbakicept-PMLN) for both approved and additional future indications, pending necessary regulatory approvals.

Which Key Players Are Driving Competition In The Therapeutic BCG Vaccines Market?

Major companies operating in the therapeutic bcg vaccines market include Merck & Co Inc., Sanofi Pasteur, Japan BCG Laboratory, China National Biotec Group, Serum Institute of India Pvt. Ltd., InterVax Ltd., GreenSignal Bio Pharma Limited, Statens Serum Institute, AJ Vaccines, Bul Bio-National Center of Infectious and Parasitic Diseases Ltd, Biomed Lublin S.A., Microgen, Taj Pharma Ltd., PT Bio Farma, Torlak Institute of Virology, Bacille Bilie Calmette-Guerin Laboratory, China Biotechnology Co Ltd., Bharat Biotech International Ltd., Biological E. Limited, Shanghai Institute of Biological Products Co. Ltd., Cipla Limited, Instituto Butantan

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/therapeutic-bcg-vaccines-global-market-report

Which Region Shows The Highest Potential For Future Expansion In The Therapeutic BCG Vaccines Market?

Asia-Pacific was the largest region in the therapeutic BCG vaccines market in 2024. The regions covered in the therapeutic bcg vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Therapeutic BCG Vaccines Market Report:

https://www.thebusinessresearchcompany.com/customise?id=9178&type=smp

Browse Through More Reports Similar to the Global Therapeutic BCG Vaccines Market 2025, By The Business Research Company

Wound Care Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/wound-care-devices-global-market-report

Benign Prostatic Hyperplasia Bph Treatment Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/benign-prostatic-hyperplasia-bph-treatment-devices-and-equipment-global-market-report

Pain Management Devices And Therapies Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pain-management-devices-and-therapies-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795